Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Research and License Agreement [Abstract] Research and License Agreement [Text Block] Research and License Agreement [Text Block] The entire disclosure on research and license agreement entered by the entity. Consulting Agreements [Abstract] Consulting Agreements [Text Block] Consulting Agreements [Text Block] The entire disclosure for the consulting agreements with the consultants. Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Schedule Of Share-Based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Accounting Policies [Abstract] General And Going Concern [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Class Of Stock [Domain] Class of Stock [Domain] General And Going Concern [Line Items] Stockholders Equity, Reverse Stock Split Research And License Agreement [Table] Income Statement Location [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Research And License Agreement [Line Items] Percentage Of Royalty PaymentIf Licensed Product Covered By Valid Claim Or Orphan Drug Status Percentage Of Royalty Payment If Licensed Product Covered By Valid Claim Or Orphan Drug Status This element represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is covered by a Valid Claim or is covered by Orphan Drug Status Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status This element represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such Licensed Product is not covered by a Valid Claim or is not covered by Orphan Drug Status. Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status. Consulting Agreement [Table] Title of Individual [Axis] Deferred Bonus and Profit Sharing Plan by Title of Individual [Axis] Title Of Individual With Relationship To Entity [Domain] Title of Individual with Relationship to Entity [Domain] Eldad Melamed and Daniel Offen Consultants [Member] Prof Daniel Offen Consultant [Member] Prof.Daniel Offen Consultant [Member] Consultants [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Monthly Payment Of Consulting Fees Monthly Payment Of Consulting Fees Monthly payment of consulting fees paid. Monthly Payment Of Consulting Fees Cash Monthly Payment Of Consulting Fees, Cash Monthly payment of consulting fees in cash. Monthly Payment Of Consulting Fees Stock Monthly Payment Of Consulting Fees, Stock Monthly payment of consulting fees in stock, value. Research and Development Expense Research and Development Expense Research and development, net Research and Development Expense Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Employee Stock Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Number Amount of options, Outstanding at beginning of period Amount of options, Outstanding at end of period Options outstanding at end of period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross Amount of options, Granted Number of warrants issued Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period Amount of options, Exercised Exercised Exercise of options (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period Amount of options, Cancelled Forfeited Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Number Amount of options, Vested and expected-to-vest at end of period Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Outstanding at beginning of period (in dollars per share) Weighted average exercise price, Outstanding at end of period (in dollars per share) Exercise price (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Grants In Period, Weighted Average Exercise Price Weighted average exercise price, Granted (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Exercise Price Weighted average exercise price, Exercised (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Exercise Price Weighted Average exercise Price, Cancelled (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Vested and expected-to-vest at end of period (in dollars per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value, Outstanding at end of period (in dollars) Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value, Vested and expected-to-vest at end of period (in dollars) Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, At Carrying Value Cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at end of the period Short-term Investments Short-term deposit (Note 6) Nontrade Receivables, Current Account receivable Prepaid Expense, Current Prepaid expenses Assets, Current Total current assets Assets, Noncurrent [Abstract] Long-Term Assets: Prepaid Expense, Noncurrent Prepaid expenses Long-Term Investments Total long-term investments Property, Plant and Equipment, Net Property and Equipment, Net Depreciated cost Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Trade payables Accrued Liabilities, Current Accrued expenses Accounts Payable, Other, Current Other accounts payable Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-Term Liabilities: Warrants and Rights Outstanding Warrants issued to investors Liabilities, Noncurrent, Total Total long-term liabilities Liabilities Total liabilities Stockholders Equity Attributable To Parent [Abstract] Stockholders' Equity: Common Stock, Value, Issued Stock capital: (Note 7) Common stock of $0.00005 par value - Authorized: 800,000,000 shares at June 30, 2015 and December 31, 2014; Issued and outstanding: 18,480,957 and 15,281,497shares at June 30, 2015 and December 31, 2014 respectively. Additional Paid In Capital, Common Stock Additional paid-in-capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders Equity Attributable To Parent Total stockholders' equity Balance Balance Liabilities and Equity Total liabilities and stockholders' equity Equity Components [Axis] Statement, Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Warrant [Member] Vesting [Axis] Vesting [Domain] Issuance Date Nov - Dec 2004 [Member] Issuance Date Feb - Dec 2005 [Member] Issuance Date Feb - Dec 2006 [Member] Issuance Date Mar Nov 2007 [Member] Issuance Date Mar - Nov 2007 [Member] Issuance Date Nov 2008 [Member] Issuance Date Apr - Oct 2009 [Member] Issuance Date Aug 2007 - Jan 2011 [Member] Issuance Date Jan 2010 [Member] Issuance Date Feb 2010 [Member] Issuance Date Feb 2010 One [Member] Issuance Date Feb 2010 Two [Member] Issuance Date Feb 2011 [Member] Issuance Date Feb 2011 One [Member] Issuance Date Feb 2011 Two [Member] Issuance Date July 2012 [Member] Issuance Date July 2012 One [Member] Issuance Date Feb 2013 [Member] Issuance Date Apr 2010-2014 [Member] Issuance Date Aug 2013 [Member] Issuance Date Aug 2013 One [Member] Issuance Date June 2014 [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Maximum [Member] Class of Warrant or Right, Outstanding Outstanding Investment Warrants, Exercise Price Exercise Price (in dollars per share) Investment Warrants, Exercise Price Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Number Warrants Exercisable Options exercisable Warrant Exercisable Term Exercisable through Date the warrants or rights are exercisable, in CCYY-MM-DD format. Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Research and Development Expense [Member] Research and development [Member] General and Administrative Expense [Member] General and administrative [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation, Total Total stock-based compensation expense Subsidiary, Sale Of Stock [Axis] Subsidiary, Sale of Stock [Axis] Sale Of Stock, Name Of Transaction [Domain] Sale of Stock, Name of Transaction [Domain] Private Placement [Member] Public Offering [Member] Investors Private Placement [Member] Common Stock [Member] Warrant Issued One [Member] Warrant Issued One Member. Warrant Issued Two [Member] Warrant Issued Two Meber. Unregistered Shares of Common Stock [Member] Related Party [Member] Related Party Member. Leader Underwriters1993 Ltd [Member] Leader Underwriters (1993) Ltd [Member] Leader Underwriters (1993) Ltd Member Investor [Member] Holders of Warrants [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Option Indexed To Issuer'S Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Axis] Option Indexed To Issuer'S Equity, Type [Domain] Option Indexed to Issuer's Equity, Type [Domain] Global Share Option Plan2004 and U S Stock Option and Incentive Plan2005 [Member] Global Share Option Plan 2004 and U S Stock Option and Incentive Plan 2005 [Member] Global Share Option Plan 2004 [Member] Global Share Option Plan 2004 Member. Global Share Option Plan 2014 and U S Stock Option and Incentive Plan 2014 [Member] Director [Member] Director One [Member] Director One Member. Hadasit [Member] Hadasit Member. Mr Israeli [Member] Mr. Israeli [Member] Mr Israeli Member. Chief Executive Officer [Member] Mr Schor [Member] Mr. Schor [Member] Investor One [Member] Investor Two [Member] Investor Three [Member] Restricted Stock [Member] Enrollment Of One Third Of Patients [Member] Enrollment Of All Patients [Member] Completion Of Study [Member] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Legal Advisor [Member] Scientific Advisory Board [Member] Scientific Advisory Board Member. Service Provider [Member] Placement Agent [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Investment Agreement [Member] Investment Agreement Member. Stock Issued Stock issued for warrants exchange Agreement [Axis] Stock Issued During Period, Shares, New Issues Issuance of shares for public offering (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Authorized Increase In Number Of Shares Available For Issuance Shares Reserved For Issuance Under Stock Option Plan Shares Reserved For Issuance Under Stock Option Plan The number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding as of the balance sheet date, including vested. Unit Sold Comprised Of One Share and One Warrant Unit Sold Comprised Of One Share and One Warrant Number of units sold comprised of one share and one warrant. Stock Based Compensation Recorded In General and Administrative Expenses Stock Based Compensation Recorded In General and Administrative Expenses The amount refers to stock based compensation that was recorded in general and administrative expenses. Proceeds From Issuance Of Common Stock Proceeds from issuance of Common stock, net Proceeds from issuance of Common stock, net Common Stock Purchase Price Common Stock Purchase Price Price of a single share of a number of saleable stocks of a company. Common Stock, Value, Subscriptions Common Stock, Value, Subscriptions Warrants Issued To Purchase Of Common Stock Warrants Issued To Purchase Of Common Stock Number of warrants issued to purchase of common stock. Warrant Expiry Term Warrant Expiry Term Term of warrants. Investment Options, Exercise Price Investment Options, Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award Number of options granted Stock Issued During Period, Shares, Issued For Services Stock Issued During Period, Shares, Issued for Services Stock Issued During Period, Shares, Conversion Of Convertible Securities Stock Issued During Period, Shares, Conversion of Convertible Securities Conversion of convertible loans (in shares) Stock Issued During Period, Value, Issued For Services Stock Issued During Period, Value, Issued for Services Stock Option Expiration Term Stock Option Expiration Term Stock option expiration term. Stock Based Compensation Recorded In Research Development Expenses Stock Based Compensation Recorded In Research Development Expenses The amount refers to stock based compensation that was recorded in research development expenses. Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Premium On Warrant Exercise Price Compared To Issuance Price Premium on warrant exercise price compared to issuance price. Percentage Of Warrants Issued Out Of Shares Issued In Public Offering Percentage of warrants issued out of shares issued in public offering. Warrants Issued To Placement Agent For Purchase Of Common Stock Warrants Issued To Placement Agent For Purchase Of Common Stock Number of warrants issued to placement agent for purchase of common stock. Stock Issued During Period, Shares, Restricted Stock Award, Net Of Forfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Amount Due To Investors Amount Due To Investors Carrying amount as of the balance sheet date of obligations due to investors. Number Of Warrants Vest Over Course Of Trails This element represents number of warrants vesting over the course of the trials. Common Stock, Par Or Stated Value Per Share Common stock, par value (in dollars per share) Warrants To Purchase Common Stock Shares Ratio Warrants To Purchase Common Stock Shares, Ratio This element represents warrants to purchase number of shares of common stock for every shares purchased. Stock Issued During Period, Value, New Issues Amount raised in Public offering Issuance of shares for public offering Stock Issued During Period, Value, Conversion of Convertible Securities Conversion of convertible loans Stock Based Compensation Will Be Recorded In General And Administrative Expenses The amount refers to stock based compensation that will be recorded in general and administrative expenses. Proceeds from Issuance of Warrants Percentage Of Cash Fee On Gross Proceeds Of Offering Percentage of cash fee on gross proceeds of offering. Conversion of Stock, Shares Converted Deferred Compensation Arrangement with Individual, Maximum Contractual Term Fair Value Assumptions, Weighted Average Volatility Rate Fair Value Assumptions, Risk Free Interest Rate Fair Value Assumptions, Expected Dividend Rate Fair Value Assumptions, Expected Term Stock Repurchased During Period, Value Shares Issued, Price Per Share Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Warrants Issued to Purchase of Common Stock, Percentage of Discount Percentage of discount on issue and sale of common stock. Subsequent Event [Table] Stock Issue [Axis] Stock Issue [Domain] Balance Sheet Parenthetical [Abstract] Balance Sheet Parenthetical Statement, Scenario [Axis] Scenario, Unspecified [Domain] Common Stock, Shares Authorized Common stock, shares Authorized Common Stock, Shares, Issued Common stock, shares Issued Common Stock, Shares, Outstanding Common stock, shares outstanding Income Statement [Abstract] Operating Expenses [Abstract] Operating costs and expenses: General and Administrative Expense General and administrative Operating Income (Loss) Operating profit (loss) Financial Expenses Income Net Financial (income) expenses, net Amount of financial expenses (income), net during the period. Net Income (Loss) Attributable To Parent Net profit (loss) Net loss Net loss Income (Loss) From Continuing Operations, Per Basic and Diluted Share Basic and diluted net profit (loss) per share from continuing operations (in dollars per share) Weighted Average Number Of Shares Outstanding, Basic and Diluted Weighted average number of shares outstanding used in computing basic and diluted net loss per share (in shares) Statement Of Stockholders Equity [Abstract] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated deficit [Member] Shares, Outstanding Balance (in shares) Balance (in shares) Stock Granted During Period, Value, Share-Based Compensation, Net Of Forfeitures Stock-based compensation related to warrants and stock granted to service providers Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Net Of Forfeitures Stock-based compensation related to warrants and stock granted to service providers (in shares) Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees (in shares) Stock Issued During Period For Private Placement Value Issuance of shares for private placement Value of stock issued for private placement during the period. Stock Issued During Period Shares Private Placement Issuance of shares for private placement (in shares) Number of shares issued for private placement during the period. Stock Issued During Period, Value, Issued for warrants exchange Stock issued for warrants exchange Value of stock issued as a result of the warrants exchange. Stock Issued During Period, Shares, Issued for warrants exchange Stock issued for warrants exchange (in shares) Number of shares issued as a result of the warrants exchange. Adjustments to Additional Paid in Capital, Warrant Redemption in Cash Warrants liability classified as equity Amount of increase in additional paid in capital (APIC) resulting from the warrants redemption in cash. Stock Issued During Period, Value, Exercise Of Warrants Exercise of warrants Value of stock issued during the period as a result of exercise of warrants Stock Issued During Period, Shares, Exercise Of Warrants Exercise of warrants (in shares) Number of shares issued during the period as a result of exercise of warrants Stock Issued During Period, Value, Stock Options Exercised Exercise of options Exercise and Reissuance of Warrants Value Exercise and reissuance of warrants Value of stock issued during the period as a result of exercise and reissuance of warrants. Exercise and reissuance of warrants Exercise and reissuance of warrants (in shares) Number of shares issued during the period as a result of exercise of warrants Statement Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Other Depreciation and Amortization Depreciation and amortization of deferred charges Issuance of Stock and Warrants for Services or Claims Expenses related to shares and options granted to service providers Stock Or Unit Option Plan Expense Amortization of deferred stock-based compensation related to options granted to employees and directors Increase In Accounts Receivable and Prepaid Expenses Decrease (increase) in accounts receivable and prepaid expenses The increase (decrease) during the reporting period in accounts receivable and prepaid expenses. Increase (Decrease) In Accounts Payable, Trade Increase (decrease) in trade payables Increase (Decrease) In Other Accounts Payable and Accrued Liabilities Increase (decrease) in other accounts payable and accrued expenses Fair Value Adjustment of Warrants Revaluation of warrants Net Cash Provided by (Used in) Operating Activities, Continuing Operations Total net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments To Acquire Property, Plant, and Equipment Purchase of property and equipment Payments for (Proceeds from) Short-term Investments, Total Changes in short-term deposit Investment In Lease Deposit Investment in lease deposit Amount of investment made in the form of lease deposit during the year. Net Cash Provided by (Used in) Investing Activities, Continuing Operations Total net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Proceeds From Issuance Of Equity Proceeds from issuances of common stock through equity warrants and options exercises Proceeds from Issuance of Equity, Total. Proceeds From Issuance Or Sale Of Equity Proceeds from equity offering through issuances of equity warrants and common stock through the exercise of previously issued equity warrants Payments for Repurchase of Warrants Redemption of warrants in cash Cash and Cash Equivalents, Period Increase (Decrease) Increase (decrease) in cash and cash equivalents Noncash Investing and Financing Items [Abstract] Non-cash financing activities: Conversion of Stock, Amount Converted Warrants liability classified as equity Noncash Financing Activities Total non-cash financing activities Aggregate amount of in financing activities noncash transactions. General and Going Concern Disclosure [Abstract] Business Description and Basis of Presentation [Text Block] Business Description and Basis of Presentation [Text Block] Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Significant Accounting Policies [Text Block] Quarterly Financial Information Disclosure [Abstract] Quarterly Financial Information [Text Block] Share Price Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule Of Warrants Issued To Investors Service Providers [Table Text Block] Schedule Of Employee Service Share-Based Compensation, Allocation Of Recognized Period Costs [Table Text Block] Stock Based Compensation Expense [Table Text Block] Issuance Date June 2014 One [Member] Maxim Group LLC [Member] Warrants Repurchase Price It represents warrant repurchase price per share. Warrants Exercisable Terms Description It represents the terms and conditions for exercise of warrants. Issuance Date Jan 2015 [Member] Exercise of liability classified warrants Value of liability raised during the period as a result of exercise of warrants Exercise of Liability Classified Warrants Shares Exercise of liability classified warrants (in shares) It represents exercise of classified liability of warrants shares. Exercise of equity classified warrants Exercise of equity classified warrants Value of equity issued during the period as a result of exercise of warrants Exercise of equity classified warrants in share Exercise of equity classified warrants (in shares) It represents number of shares issued during the period as a result of exercise of warrants Proceeds from Warrant Exercises Exercise Agreement, Maxim Cash Fee, Percentage It represents percentage of maxim cash fee exercise agreement Exercise Agreement, Fees and Expenses, Amount It represents amount of exercise agreement fees and expenses, Consulting Agreement [Line Items] Subsequent Event [Line Items] Agreement [Domain] Settlement Agreement [Member] Document Information [Line Items] Cash and Cash Equivalents [Abstract] Short Term Investments [Text Block] he entire disclosure of the components short-term investments. Short-term investments may include current marketable securities. Legal Entity [Axis] Entity [Domain] Percentage Of Interest Bearing Bank Deposits Percentage of interest-bearing bank deposits. Interest Bearing Bank Deposits Maturity Date Interest bearing bank deposits maturity period. Cash and Cash Equivalents [Line Items] Officers' Compensation Chief Financial Officer [Member] Net Cash Provided by (Used in) Financing Activities, Continuing Operations Total net cash provided by financing activities New Equity Warrants [Member]